000878350 001__ 878350
000878350 005__ 20210130005555.0
000878350 0247_ $$2doi$$a10.1070/RCR4954
000878350 0247_ $$2ISSN$$a0036-021X
000878350 0247_ $$2ISSN$$a1468-4837
000878350 0247_ $$2Handle$$a2128/25477
000878350 0247_ $$2WOS$$aWOS:000557617800001
000878350 037__ $$aFZJ-2020-02797
000878350 041__ $$aEnglish
000878350 082__ $$a540
000878350 1001_ $$0P:(DE-HGF)0$$aZlatopolskiy, B. D.$$b0
000878350 245__ $$a11C- and 18F-labelled tryptophans as PET-tracers for imaging of altered tryptophan metabolism in age-associated disorders
000878350 260__ $$a[Letchworth]$$bTurpion$$c2020
000878350 3367_ $$2DRIVER$$aarticle
000878350 3367_ $$2DataCite$$aOutput Types/Journal article
000878350 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1597156273_26594
000878350 3367_ $$2BibTeX$$aARTICLE
000878350 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000878350 3367_ $$00$$2EndNote$$aJournal Article
000878350 520__ $$aThe ageing of the world's population is the result of increased life expectancy observed in almost all countries throughout the world. Consequently, a rising tide of ageing-associated disorders, like cancer and neurodegenerative diseases, represents oneof the main global challenges of the 21st century. The ability of mankind to overcome these challenges is directly dependent on the capability to develop novel methods for therapy and diagnosis of age-associated diseases. One hallmark of age-relatedpathologies is an altered tryptophan metabolism. Numerous pathological processes including neurodegenerative and neurological diseases like epilepsy, Parkinson's and Alzheimer's diseases, cancer and diabetes exhibit marked changes intryptophan metabolism. Visualization of key processes of tryptophan metabolic pathways, especially using positron emission tomography (PET) and related hybrid methods like PET/CT and PET/MRI, can be exploited to early detect theaforementioned disorders with considerable accuracy, allowing appropriate and timely treatment of patients. Here we review the published 11C- and 18F-labelled tryptophans with respect to the production and also preclinical and clinical evaluation asPET-tracers for visualization of different branches of tryptophan metabolism.The bibliography includes 159 references.
000878350 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000878350 588__ $$aDataset connected to CrossRef
000878350 7001_ $$0P:(DE-Juel1)180330$$aEndepols, H.$$b1$$ufzj
000878350 7001_ $$0P:(DE-HGF)0$$aKrasikova, R. N.$$b2
000878350 7001_ $$0P:(DE-HGF)0$$aFedorova, O. S.$$b3
000878350 7001_ $$0P:(DE-Juel1)131818$$aErmert, J.$$b4$$ufzj
000878350 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, B.$$b5$$eCorresponding author$$ufzj
000878350 773__ $$0PERI:(DE-600)1474827-7$$a10.1070/RCR4954$$gVol. 89, no. 9, p. 879 - 896$$n9$$p879 - 896$$tRussian chemical reviews$$v89$$x1468-4837$$y2020
000878350 8564_ $$uhttps://juser.fz-juelich.de/record/878350/files/Imaging%20of%20altered%20tryptophan%20metabolism_final%20version.pdf$$yOpenAccess
000878350 8564_ $$uhttps://juser.fz-juelich.de/record/878350/files/Zlatopolskiy_2020_Russ._Chem._Rev._89_879.pdf$$yRestricted
000878350 8564_ $$uhttps://juser.fz-juelich.de/record/878350/files/Imaging%20of%20altered%20tryptophan%20metabolism_final%20version.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000878350 8564_ $$uhttps://juser.fz-juelich.de/record/878350/files/Zlatopolskiy_2020_Russ._Chem._Rev._89_879.pdf?subformat=pdfa$$xpdfa$$yRestricted
000878350 909CO $$ooai:juser.fz-juelich.de:878350$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000878350 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)180330$$aForschungszentrum Jülich$$b1$$kFZJ
000878350 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131818$$aForschungszentrum Jülich$$b4$$kFZJ
000878350 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b5$$kFZJ
000878350 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000878350 9141_ $$y2020
000878350 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000878350 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bRUSS CHEM REV+ : 2018$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2020-01-03$$wger
000878350 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-01-03
000878350 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2020-01-03$$wger
000878350 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-01-03
000878350 920__ $$lyes
000878350 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000878350 980__ $$ajournal
000878350 980__ $$aVDB
000878350 980__ $$aUNRESTRICTED
000878350 980__ $$aI:(DE-Juel1)INM-5-20090406
000878350 9801_ $$aFullTexts